Patent · US Active

Use of hepcidin as a regulator of iron homeostasis

US10004784B2 · kind B2 · utility

0Cited by

8References

23Claims

0Family size

Assignee

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Gael Nicolas · Paris, FR
Sophie Vaulont · Paris, FR
Axel Kahn · Paris, FR

Key dates

Filing date	Aug 9, 2017
Grant date	Jun 26, 2018
Priority date	—
Expiry date	Aug 9, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/90
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anaemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.